FDA Okays Wearable Device for Opioid Withdrawal FDA Okays Wearable Device for Opioid Withdrawal

The FDA has cleared an auricular neurostimulation device to help reduce symptoms of opioid withdrawal, including cravings, agitation, anxiety, and depression.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Psychiatry News Alert Source Type: news

Related Links:

Conclusions: The present results showed that the training of spiritual intelligence could develop the nurses' competence in spiritual care. The development of spiritual care provided by nurses can result in various outcomes such as increased satisfaction with care in patients, reduced anxiety and symptoms of depression during hospitalization, reduced length of hospitalization and, in general, improved quality of life. PMID: 30894893 [PubMed - in process]
Source: Journal of Medicine and Life - Category: General Medicine Tags: J Med Life Source Type: research
The more mental health problems people had early on, the greater their memory problems in later life. → Support PsyBlog for just $4 per month. Enables access to articles marked (M) and removes ads. → Explore PsyBlog's ebooks, all written by Dr Jeremy Dean: Accept Yourself: How to feel a profound sense of warmth and self-compassion The Anxiety Plan: 42 Strategies For Worry, Phobias, OCD and Panic Spark: 17 Steps That Will Boost Your Motivation For Anything Activate: How To Find Joy Again By Changing What You Do
Source: PsyBlog | Psychology Blog - Category: Psychiatry & Psychology Authors: Tags: Depression subscribers-only Source Type: blogs
Conditions:   Depression;   Anxiety;   PTSD;   Conduct Disorder;   Oppositional Defiant Disorder Interventions:   Behavioral: t-CETA;   Behavioral: Médecins du Monde treatment as usual Sponsors:   Queen Mary University of London;   Médecins du Monde;   American University of Beirut Medical Center;   Johns Hopkins University;   Medical School Hamburg Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
CONCLUSION: The present findings documented distinct differences in somatosensory function in patients with primary BMS compared to controls, indicating a complex pathophysiology and interaction between impairments in nociceptive processing and psychologic functioning. PMID: 30893407 [PubMed - as supplied by publisher]
Source: Journal of Orofacial Pain - Category: ENT & OMF Tags: J Oral Facial Pain Headache Source Type: research
Authors: Marković V, Purić D, Vukosavljević-Gvozden T, Begović A Abstract The Metacognitions Questionnaire (MCQ-30) is a brief multidimensional measure used for assessment of metacognitive beliefs in psychopathology. The aim of this study was to assess the psychometric properties of MCQ-30 in Serbian non-clinical (n=246) and clinical (n=171; anxiety and depressive disorders) samples. The reliability of the questionnaire and its subscales was satisfactory. An exploratory factor analysis yielded a five factor solution in both groups, while a confirmatory factor analysis showed a somewhat weaker fit of the model. ...
Source: Clinical Psychology and Psychotherapy - Category: Psychiatry Tags: Clin Psychol Psychother Source Type: research
AbstractAlzheimer ’s disease (AD) is the most common form of dementia characterized by the prevalent memory impairment. Mild cognitive impairment (MCI) may represent the early stage of AD, in particular when MCI patients show biomarkers consistent with AD pathology (MCI due to AD). Neuropsychiatric symptoms (NPS) f requently affect both MCI and AD patients. Cerebrospinal-fluid (CSF) tau and β-amyloid42 (A β42) levels are actually considered the most sensitive and specific biomarkers for AD neurodegeneration. In the present retrospective observational study, we evaluated CSF biomarkers and neuropsychological...
Source: Neurological Sciences - Category: Neurology Source Type: research
ConclusionParents are important figures in the process by which children with epilepsy came to acknowledge themselves being different from other children. Parents often feared divulging their child ’s epilepsy to their friends and relatives because they experienced a sense of shame, self-blame, and rejection which also increased their stress.
Source: Neurological Sciences - Category: Neurology Source Type: research
AbstractBlack men are more likely to be diagnosed with prostate cancer compared with White men. Despite advances in prevention and treatment strategies, disparities in prostate cancer among Black men persist. While research on the causes of higher incidence and mortality is ongoing, there is limited evidence in the existing literature that clearly speaks to the potential psychological or social factors that may contribute to disparities in prostate cancer incidence. Given the lack of attention to this issue, we review scientific evidence of the ways in which social factors, including socioeconomic status and racial segrega...
Source: Cancer Causes and Control - Category: Cancer & Oncology Source Type: research
Rayfield Byrd knows when it’s time to wake up every morning. The 68-year-old Oakland, Cal., resident hears a voice from the living room offering a cheery good morning. Except Byrd lives alone. A little after 8 a.m. each day, a small yellow robot named Mabu asks Byrd how he’s doing. Byrd has Type 2 diabetes and congestive heart failure, and about three years ago, he had surgery to implant a microvalve in his heart to keep his blood flowing properly. To stay healthy, he takes four medications a day and needs to exercise regularly. To make sure his heart is still pumping effectively, his doctor needs to stay on to...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized Artificial Intelligence Life Reinvented medicine Source Type: news
Adults with sickle cell disease (SCD) have episodic crisis pain and chronic pain. Little is known about SCD chronic pain phenotypes. Quantitative sensory testing (QST) identifies the objective contribution of allodynia and hyperalgesia to chronic SCD pain phenotypes. However, self-report measures are needed to further characterize SCD chronic pain phenotypes. Our aim was to determine associations among QST-determined sensitization and anxiety, depression, and fatigue among outpatients with SCD. In a cross-sectional study, subjects (N=186, mean age 36.6 ± 11.7 years [19-74 years], 97% African American, 59% female; SC...
Source: The Journal of Pain - Category: Materials Science Authors: Source Type: research
More News: Anxiety | Brain | Depression | Health | Neurology | Psychiatry